期刊文献+

Erectile dysfunction in nonmuscle-invasive bladder cancer patients before and after transurethral resection(TUR)of bladder tumor in China

原文传递
导出
摘要 The aim of this study was to investigate the incidence of erectile dysfunction(ED)in nonmuscle-invasive bladder cancer(NMIBC)patients before and after transurethral resection(TUR)in China.Clinical data from 165 male patients with NMIBC who received adjuvant intravesical chemotherapy after TUR in Neijiang First People’s Hospital(Neijiang,China)between January 2010 and June 2019 were retrospectively reviewed.The sexual function of these patients was evaluated before and 1.5 years after initial TUR by the International Index of Erectile Function-5(IIEF-5).An age-specific subanalysis was performed among the patients:<45 years old(Group 1,n=19)and≥45 years old(Group 2,n=146).Before and 1.5 years after TUR,the incidence rates of ED in Group 1 were 15.8%and 52.6%,and those in Group 2 were 54.1%and 61.0%,respectively.The difference between groups was statistically significant at the preoperative stage(15.8%vs 54.1%,P=0.002)but not at the postoperative stage(52.6%vs 61.0%,P=0.562).Compared with the preoperative stage,the incidence of ED at the postoperative stage was increased significantly in Group 1(15.8%vs 52.6%,P=0.017)but not in Group 2(54.1%vs 61.0%,P=0.345).In conclusion,the incidence of ED increased in male NMIBC patients under the age of 45 years after TUR in China.These patients should be offered professional counseling during the follow-up period.
出处 《Asian Journal of Andrology》 SCIE CAS CSCD 2022年第5期509-512,共4页 亚洲男性学杂志(英文版)
  • 相关文献

参考文献2

二级参考文献12

  • 1Ministry of Health. National death survey report,2004-2005[M].Beijing:Peking Union Medical College Publication House,2008.
  • 2Lu FZ,Zhang SW,Chen YH. Investigation analysis of cancer registration in China[J].Zhong Guo Zhong Liu,2004.134-41.
  • 3Chen WQ,Zhao P,Rao KQ. A primary cancer registration system in China,2010[J].Zhonghua Yufang Yixue Zazhi,2010.374-5.
  • 4National Office for Cancer Prevention and Control.China cancer annual report,2010[M]北京:军事医学科学出版社,2011.
  • 5Curado MP,Edwards B,Shin HR. Cancer Incidence in Five Continents,Vol.Ⅸ[A].Lyon:iarc Press,2007.
  • 6Parkin DM,Chen VW,Ferlay J. Comparability and quality control in cancer registration.[=IARC Technical Report No.19,][R].Lyon:iarc Press,1994.
  • 7Felay J,Burkhard C,Whelan S. Check and conversion programs for cancer registries.[IARC Technical Report No.42.][R].Lyon:iarc Press,2005.
  • 8Chen WQ,Zhang SW,Zou XN. Cancer incidence and mortality in China,2006[J].Chinese Journal of Cancer Research,2011.3-9.
  • 9Chen WQ,Zheng RS,Zeng HM. Bayesian age-period-cohort prediction of lung cancer incidence in China[J].Thoracic Cancer,2011.149-55.
  • 10Shopland DR,Eyre H J,Pechacek TF. Smoking-attributable cancer mortality in,1991:is lung cancer now the leading cause of death among smokers in the United States[J].Journal of the National Cancer Institute,1991.1142-8.

共引文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部